0001415889-24-001783.txt : 20240124 0001415889-24-001783.hdr.sgml : 20240124 20240124202646 ACCESSION NUMBER: 0001415889-24-001783 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240124 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cui Xiangmin CENTRAL INDEX KEY: 0001487815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 24558340 MAIL ADDRESS: STREET 1: NO. 14 EAST HUSHAN ROAD STREET 2: TAI'AN CITY CITY: SHANDONG STATE: F4 ZIP: 000000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital Global Life Sciences Fund IV, L.P. CENTRAL INDEX KEY: 0001834150 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 24558342 BUSINESS ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, P.O. BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8066 MAIL ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, P.O. BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital Management IV (Cayman), LLC CENTRAL INDEX KEY: 0001843384 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 24558341 BUSINESS ADDRESS: STREET 1: P.O. BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: (650) 233-0688 MAIL ADDRESS: STREET 1: P.O. BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CG Oncology, Inc. CENTRAL INDEX KEY: 0001991792 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371611499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 419-6203 MAIL ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 3 1 form3-01252024_010140.xml X0206 3 2024-01-24 0 0001991792 CG Oncology, Inc. CGON 0001834150 Decheng Capital Global Life Sciences Fund IV, L.P. UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 CAYMAN ISLANDS false false true false 0001843384 Decheng Capital Management IV (Cayman), LLC UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 CAYMAN ISLANDS 0 0 1 0 0001487815 Cui Xiangmin UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 CAYMAN ISLANDS 0 0 1 0 Common Stock 930612 D Series C Preferred Stock Common Stock 906646 D Series E Preferred Stock Common Stock 2259851 D Series F Preferred Stock Common Stock 461701 D These reportable securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV"). Decheng Capital Management IV (Cayman), LLC ("GP IV") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein. Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. All share numbers reported in this Form 3 reflect a 1-for-9.535 reverse stock split for the Issuer's common stock, effected by the Issuer on January 16, 2024. Decheng Capital Global Life Sciences Fund IV, L.P., By Decheng Capital Management IV (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager 2024-01-24 Decheng Capital Management IV (Cayman), LLC, By /s/ Xiangmin Cui, Manager 2024-01-24 /s/ Xiangmin Cui 2024-01-24